47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.38.Z - Wholesale trade of other food products
47.29.Z - Retail trade
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,8 | 0,8 | 1,1 | 25,3 |
Gross profit (loss) | 1 | 1,1 | 1,2 | 12,5 |
EBITDA | 1 | 1,1 | 1,3 | 17,5 |
Short time liabilities | 1,1 | 1,3 | 1,3 | 2,3 |
Other operating costs | 0,1 | 0 | 0 | -16,3 |
Equity capital | 0,2 | 0,2 | 0,4 | 82,7 |
Operating profit (EBIT) | 1 | 1,1 | 1,3 | 17,5 |
Assets | 1,3 | 1,5 | 1,7 | 13,2 |
Net profit (loss) | 1 | 1,1 | 1,2 | 12,5 |
Cash | 0,2 | 8,6 | ||
Net income from sale | 7,6 | 8,9 | 9,4 | 6,5 |
Liabilities and provisions for liabilities | 1,1 | 1,3 | 1,3 | 2,3 |
Working assets | 1,3 | 1,5 | 1,7 | 13,3 |
Other income costs | 0,3 | 0,3 | 0,3 | -8,8 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 503,2 | 542 | 333,7 | -208,3 |
Equity capital to total assets | 15,8 | 13,6 | 21,9 | 8,3 |
Gross profit margin | 13,2 | 12,2 | 12,9 | 0,7 |
EBITDA Margin | 13,3 | 12,5 | 13,8 | 1,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 51 | 52 | 50 | -2 |
Current financial liquidity indicator | 1.1832144260406494 | 1.1540518999099731 | 1.2781437635421753 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane